GSE103510 STAT5 inhibition 1 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE103510_STAT5 inhibition_1_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE103510_STAT5 inhibition_1_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE103510_STAT5 inhibition_1_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE103510_STAT5 inhibition_1_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

interferon alpha inducible protein 27

Gene

DnaJ heat shock protein family (Hsp40) member A3

Gene

eukaryotic translation initiation factor 5A

Gene

cell division cycle 20

Gene

activated leukocyte cell adhesion molecule

Gene

interferon alpha inducible protein 6

Gene

lysozyme

Gene

toll like receptor 4

Gene

pleckstrin homology like domain family A member 1

Gene

serglycin

  • Gene

    interferon alpha inducible protein 27


  • Gene

    DnaJ heat shock protein family (Hsp40) member A3


  • Gene

    eukaryotic translation initiation factor 5A


  • Gene

    cell division cycle 20


  • Gene

    activated leukocyte cell adhesion molecule


  • Gene

    interferon alpha inducible protein 6



  • Gene

    toll like receptor 4


  • Gene

    pleckstrin homology like domain family A member 1


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.